FDA Inspection 920704 — Whitney Labs LP

Whitney Labs LP — FEI 3000204465

The FDA completed an inspection of Whitney Labs LP on March 31, 2015 in Ormond Beach, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 21 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 31, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Ormond Beach, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
145021 CFR 211.113(a)Procedures for non-sterile drug products
154021 CFR 211.125(a)Strict control not exercised over labeling issued
200321 CFR 211.184(c)Individual inventory record
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
200921 CFR 211.188Prepared for each batch, include complete information
202621 CFR 211.192Quality control unit review of records
202721 CFR 211.192Investigations of discrepancies, failures
204421 CFR 211.196Distribution Record Requirements
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
358321 CFR 211.110(a)Written in-process control procedures
362921 CFR 211.170(b)Reserve samples identified, representative, stored
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.
439121 CFR 211.180(e)(2)Items to cover on annual reviews
673021 CFR 314.80(b)Failure to develop written procedures
891121 CFR 314.81(b)(1)(ii)Failure to meet specifications